https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Cytotherapy 2004;6(2):154-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Cytotherapy 2004;6(2):154-632004-01-01 00:00:002019-02-15 08:50:27The immune response to breast cancer, and the case for DC immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Cytotherapy 2004;6(1):62-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Cytotherapy 2004;6(1):62-72004-01-01 00:00:002019-02-15 08:51:06DC-based immunotherapy of B-cell malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Int. J. Mol. Med. 2004 Jan;13(1):33-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Int. J. Mol. Med. 2004 Jan;13(1):33-92004-01-01 00:00:002019-02-15 08:53:30Thyroglobulin-pulsed human monocyte-derived dendritic cells induce CD4+ T cell activation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Breast Dis 2004;20:65-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Breast Dis 2004;20:65-712004-01-01 00:00:002004-01-01 00:00:00Dendritic cell-based therapeutics for breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / BJU Int. 2004 Jan;93(1):36-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / BJU Int. 2004 Jan;93(1):36-412004-01-01 00:00:002019-02-15 10:00:39Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2003 Dec;17(4):365-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2003 Dec;17(4):365-82003-12-01 00:00:002019-02-15 08:37:48[Antiviral effect of human CTLs activated by HBsAg stimulated dendritic cells in vitro]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Hum. Cell 2003 Dec;16(4):175-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Hum. Cell 2003 Dec;16(4):175-822003-12-01 00:00:002019-02-15 08:46:08Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Curr. Opin. Mol. Ther. 2003 Dec;5(6):618-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Curr. Opin. Mol. Ther. 2003 Dec;5(6):618-242003-12-01 00:00:002019-02-15 09:22:25Overview of phase I studies of intravenous administration of PV701, an oncolytic virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-82003-12-01 00:00:002019-02-15 08:51:25Dendritic cell-based immunotherapy in multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-11-03 / Br. J. Cancer 2003 Nov;89(9):1736-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-11-03 / Br. J. Cancer 2003 Nov;89(9):1736-422003-11-03 00:00:002019-02-15 08:36:25Clinical significance of immune cell infiltration within gallbladder cancer
